Paul Borm is expert in Toxicology and entrepreneur in Life Sciences and Medical Technology and. During his 25-year academic career in Toxicology (Utrecht, Maastricht, Düsseldorf) he conducted research into lung and cardiac diseases with a clear focus on occupational health exposure. In 2004 he co-founded a high-impact journal (PFT) for particle toxicology and he is the author of close to 200 publications. For 20 years now, Nanotechnologies feed his activities on regional and global level, and provide inspiration for both his research and business activities. In 2011 he founded Nano4Imaging GmbH in Dusseldorf (DE) which focuses on improvement of cardiovascular diagnosis and interventions using MRI, and Borm is responsible for clinical evaluation, post-marketing surveillance and patent strategy. Borm acts as (strategic) consultant for several global companies and associations in the field of chemicals, minerals and particles. In 2019 Borm has initiated, guided, organized, moderated and published a consensus opinion workshop on PSLT for all relevant stakeholders. Finally, he acts as a consultant in toxicology, expert assessments and due diligence on strategic and operational level. He still teaches Toxicology at post-graduate courses in NL and Germany, and medical imaging at Dusseldorf University.
